The Effectiveness of a Body-Affective Mindfulness Intervention for Multiple Sclerosis Patients with Depressive Symptoms: A Randomized Controlled Clinical Trial

Sara Carletto, Valentina Tesio, Martina Borghi, Diana Francone, Francesco Scavelli, Gabriella Bertino, Simona Malucchi, Antonio Bertolotto, Francesco Oliva, Riccardo Torta, Luca Ostacoli, Sara Carletto, Valentina Tesio, Martina Borghi, Diana Francone, Francesco Scavelli, Gabriella Bertino, Simona Malucchi, Antonio Bertolotto, Francesco Oliva, Riccardo Torta, Luca Ostacoli

Abstract

Purpose: Mindfulness interventions have been shown to treat depressive symptoms and improve quality of life in patients with several chronic diseases, including multiple sclerosis, but to date most evaluation of the effectiveness of mindfulness interventions in multiple sclerosis have used patients receiving standard care as the control group. Hence we decided to evaluate the effectiveness of a group-based body-affective mindfulness intervention by comparing it with a psycho-educational intervention, by means of a randomized controlled clinical trial. The outcome variables (i.e., depression, anxiety, perceived stress, illness perception, fatigue and quality of life) were evaluated at the end of the interventions (T1) and after a further 6 months (T2). Methods: Of 90 multiple sclerosis patients with depressive symptoms (Beck Depression Inventory-II score greater than 13) who were randomized, 71 completed the intervention (mindfulness group n = 36; psycho-educational group n = 35). The data were analyzed with GLM repeated-measures ANOVA followed by pairwise comparisons. Results: Per-protocol analysis revealed a time by group interaction on Beck Depression Inventory-II score, with the mindfulness intervention producing a greater reduction in score than the psycho-educational intervention, both at T1 and at T2. Furthermore, the mindfulness intervention improved patients' quality of life and illness perception at T1 relative to the baseline and these improvements were maintained at the follow-up assessment (T2). Lastly, both interventions were similarly effective in reducing anxiety and perceived stress; these reductions were maintained at T2. A whole-sample intention-to-treat (ITT) analysis broadly confirmed the effectiveness of the mindfulness intervention. Conclusion: In conclusion, these results provide methodologically robust evidence that in multiple sclerosis patients with depressive symptoms mindfulness interventions improve symptoms of depression and anxiety and perceived stress, modulate illness representation and enhance quality of life and that the benefits are maintained for at least 6 months. Trial registration: the study was registered in the ClinicalTrials.gov registry (NCT02611401).

Keywords: depression; mindfulness; mindfulness based intervention; multiple sclerosis; psycho-education; quality of life.

Figures

FIGURE 1
FIGURE 1
Participants flow diagram.

References

    1. Beck A. T., Epstein N., Brown G., Steer R. A. (1988). An inventory for measuring clinical anxiety: psychometric properties. J. Consult. Clin. Psychol. 56 893–897. 10.1037/0022-006X.56.6.893
    1. Beck A. T., Steer R. A. (1993). Beck Anxiety Inventory Manual. San Antonio, TX: The Psychological Corporation.
    1. Beck A. T., Steer R. A., Brown G. K. (1996). Beck Depression Inventory-II Vol. 78 San Antonio, TX: The Psychological Corporation; 490–498
    1. Beiske A. G., Svensson E., Sandanger I., Czujko B., Pedersen E. D., Aarseth J. H., et al. (2008). Depression and anxiety amongst multiple sclerosis patients. Eur. J. Neurol. 15 239–245. 10.1111/j.1468-1331.2007.02041.x
    1. Berkovits I., Hancock G., Nevitt J. (2000). Bootstrap resampling approaches for repeated measures designs: relative robustness to sphericity and normality violations. Educ. Psychol. Meas. 60 877–892. 10.1177/00131640021970961
    1. Boeschoten R. E., Braamse A. M., Beekman A. T., Cuijpers P., van Oppen P., Dekker J., et al. (2017). Prevalence of depression and anxiety in multiple sclerosis: a systematic review and meta-analysis. J. Neurol. Sci. 372 331–341. 10.1016/j.jns.2016.11.067
    1. Bogosian A., Chadwick P., Windgassen S., Norton S., McCrone P., Mosweu I., et al. (2015). Distress improves after mindfulness training for progressive MS: a pilot randomised trial. Mult. Scler. J. 21 1184–1194. 10.1177/1352458515576261
    1. Broadbent E., Petrie K. J., Main J., Weinman J. (2006). The brief illness perception questionnaire. J. Psychosom. Res. 60 631–637. 10.1016/j.jpsychores.2005.10.020
    1. Broadbent E., Wilkes C., Koschwanez H., Weinman J., Norton S., Petrie K. J. (2015). A systematic review and meta-analysis of the brief illness perception questionnaire. Psychol. Health 30 1361–1385. 10.1080/08870446.2015.1070851
    1. Brown R. F., Valpiani E. M., Tennant C. C., Dunn S. M., Sharrock M., Hodgkinson S., et al. (2009). Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis. Psychol. Psychother. 82(Pt 1) 41–56. 10.1348/147608308X345614
    1. Byatt N., Rothschild A. J., Riskind P., Ionete C., Hunt A. T. (2011). Relationships between multiple sclerosis and depression. J. Neuropsychiatry Clin. Neurosci. 23 198–200. 10.1176/jnp.23.2.jnp198
    1. Carletto S., Borghi M., Francone D., Scavelli F., Bertino G., Cavallo M., et al. (2016). The efficacy of a mindfulness based intervention for depressive symptoms in patients with multiple sclerosis and their caregivers: study protocol for a randomized controlled clinical trial. BMC Neurol. 16:7. 10.1186/s12883-016-0528-0.
    1. Cella D. F., Dineen K., Arnason B., Reder A., Webster K. A., Karabatsos G., et al. (1996). Validation of the functional assessment of multiple sclerosis quality of life instrument. Neurology 47 129–139. 10.1212/WNL.47.1.129
    1. Chwastiak L., Ehde D. M., Gibbons L. E., Sullivan M., Bowen J. D., Kraft G. H. (2002). Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am. J. Psychiatry 159 1862–1868. 10.1176/appi.ajp.159.11.1862
    1. Cohen S., Janicki-Deverts D. (2012). Who’s stressed? Distributions of psychological stress in the United States in probability samples from 1983, 2006 and 2009. J. Appl. Soc. Psychol. 42 1320–1334. 10.1111/j.1559-1816.2012.00900.x
    1. Cohen S., Kamarck T., Mermelstein R. (1983). A global measure of perceived stress. J. Health Soc. Behav. 24 385–396. 10.2307/2136404
    1. Crowe M., Jordan J., Burrell B., Jones V., Gillon D., Harris S. (2016). Mindfulness-based stress reduction for long-term physical conditions: a systematic review. Aust. N. Z. J. Psychiatry 50 21–32. 10.1177/0004867415607984.
    1. De Girolamo G., Rucci P., Scocco P., Becchi A., Coppa F., D’Addario A., et al. (2000). Quality of life assessment: validation of the Italian version of the WHOQOL-Brief. Epidemiol. Psychiatr. Sci. 9 45–55. 10.1017/S1121189X00007740
    1. Demarzo M. M., Montero-Marin J., Cuijpers P., Zabaleta-del-Olmo E., Mahtani K. R., Vellinga A., et al. (2015). The efficacy of mindfulness-based interventions in primary care: a meta-analytic review. Ann. Fam. Med. 13 573–582. 10.1370/afm.1863
    1. Feinstein A. (2011). Multiple sclerosis and depression. Mult. Scler. J. 17 1276–1281. 10.1177/1352458511417835
    1. Feinstein A., Magalhaes S., Richard J. F., Audet B., Moore C. (2014). The link between multiple sclerosis and depression. Nat. Rev. Neurol. 10 507–517. 10.1038/nrneurol.2014.139
    1. Fiest K. M., Walker J. R., Bernstein C. N., Graff L. A., Zarychanski R., Abou-Setta A. M., et al. (2016). Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis. Mult. Scler. Relat. Disord. 5 12–26. 10.1016/j.msard.2015.10.004
    1. Fruehwald S., Loeffler-Stastka H., Eher R., Saletu B., Baumhacki U. (2001). Depression and quality of life in multiple sclerosis. Acta Neurol. Scand. 104 257–261. 10.1034/j.1600-0404.2001.00022.x
    1. Giordano A., Ferrari G., Radice D., Randi G., Bisanti L., Solari A. (2012). Health-related quality of life and depressive symptoms in significant others of people with multiple sclerosis: a community study. Eur. J. Neurol. 19 847–854. 10.1111/j.1468-1331.2011.03638.x
    1. Goldman Consensus Group (2005). The Goldman Consensus statement on depression in multiple sclerosis. Mult. Scler. 11 328–337. 10.1191/1352458505ms1162oa
    1. Grossman P., Kappos L., Gensicke H., D’Souza M., Mohr D. C., Penner I. K., et al. (2010). MS quality of life, depression, and fatigue improve after mindfulness training A randomized trial. Neurology 75 1141–1149. 10.1212/WNL.0b013e3181f4d80d
    1. Grossman P., Tiefenthaler-Gilmer U., Raysz A., Kesper U. (2007). Mindfulness training as an intervention for fibromyalgia: evidence of postintervention and 3-year follow-up benefits in well-being. Psychother. Psychosom. 76 226–233. 10.1159/000101501
    1. Haller H., Winkler M. M., Klose P., Dobos G., Kümmel S., Cramer H. (2017). Mindfulness-based interventions for women with breast cancer: an updated systematic review and meta-analysis. Acta Oncol. 10.1080/0284186X.2017.1342862 [Epub ahead of print].
    1. Hofmann S. G., Sawyer A. T., Witt A. A., Oh D. (2010). The effect of mindfulness-based therapy on anxiety and depression: a meta-analytic review. J. Consult. Clin. Psychol. 78 169–183. 10.1037/a0018555
    1. Keng S. L., Smoski M. J., Robins C. J. (2011). Effects of mindfulness on psychological health: a review of empirical studies. Clin. Psychol. Rev. 31 1041–1056. 10.1016/j.cpr.2011.04.006
    1. Koch M. W., Glazenborg A., Uyttenboogaart M., Mostert J., De Keyser J. (2011). Pharmacologic treatment of depression in multiple sclerosis. Cochrane Database Syst. Rev. CD007295 10.1002/14651858.CD007295
    1. Krupp L. B., LaRocca N. G., Muir-Nash J., Steinberg A. D. (1989). The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch. Neurol. 46 1121–1123. 10.1001/archneur.1989.00520460115022
    1. Kuyken W., Warren F. C., Taylor R. S., Whalley B., Crane C., Bondolfi G., et al. (2016). Efficacy of mindfulness-based cognitive therapy in prevention of depressive relapse: an individual patient data meta-analysis from randomized trials. JAMA Psychiatry 73 565–574. 10.1001/jamapsychiatry.2016.0076
    1. Leventhal H., Nerenz D. R., Steele D. J. (1984). “Illness representation and coping with health threats”, in Handbook of Psychology and Health ed. Baum A., Taylor S. E., Singer J. E. (Hillsdale, NJ: Lawrence Erlbaum Associates; ) 219–252.
    1. Levin A. B., Hadgkiss E. J., Weiland T. J., Jelinek G. A. (2014). Meditation as an adjunct to the management of multiple sclerosis. Neurol. Res. Int. 2014:704691. 10.1155/2014/704691
    1. Marrie R. A., Reingold S., Cohen J., Stuve O., Trojano M., Sorensen P. S., et al. (2015). The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review. Mult. Scler. J. 21 305–317. 10.1177/1352458514564487
    1. Mills N., Allen J. (2000). Mindfulness of movement as a coping strategy in multiple sclerosis: a pilot study. Gen. Hosp. Psychiatry 22 425–431. 10.1016/S0163-8343(00)00100-6
    1. Minden S. L., Feinstein A., Kalb R. C., Miller D., Mohr D. C., Patten S. B., et al. (2014). Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 82 174–181. 10.1212/WNL.0000000000000013
    1. Mohr D. C., Goodkin D. E., Likosky W., Gatto N., Baumann K. A., Rudick R. A. (1997). Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Arch. Neurol. 54 531–533. 10.1001/archneur.1997.00550170015009
    1. Moore P., Hirst C., Harding K. E., Clarkson H., Pickersgill T. P., Robertson N. P. (2012). Multiple sclerosis relapses and depression. J. Psychosom. Res. 73 272–276. 10.1016/j.jpsychores.2012.08.004
    1. Murphy B., Herrman H., Hawthorne G., Pinzone T., Evert H. (2000). Australian WHOQoL Instruments: User’s Manual and Interpretation Guide. Melbourne, VIC: Australian WHOQOL Field Study Centre.
    1. Ogden P., Minton K., Pain C., Bhugra D. (2006). Trauma and the Body: A Sensorimotor Approach to Psychotherapy. New York, NY: W.W. Norton.
    1. Ostacoli L., Carletto S., Borghi M., Cavallo M., Rocci E., Zuffranieri M., et al. (2013). Prevalence and significant determinants of post-traumatic stress disorder in a large sample of patients with multiple sclerosis. J. Clin. Psychol. Med. Settings 20 240–246 10.1007/s10880-012-9323-2
    1. Patrick E., Christodoulou C., Krupp L. B. (2009). Longitudinal correlates of fatigue in multiple sclerosis. Mult. Scler. J. 15 258–261. 10.1177/1352458508097466
    1. Petrie K., Weinman J. (2006). Why illness perceptions matter. Clin. Med. 6 536–539. 10.7861/clinmedicine.6-6-536
    1. Piet J., Hougaard E. (2011). The effect of mindfulness-based cognitive therapy for prevention of relapse in recurrent major depressive disorder: a systematic review and meta-analysis. Clin. Psychol. Rev. 31 1032–1040. 10.1016/j.cpr.2011.05.002
    1. Polman C. H., Reingold S. C., Banwell B., Clanet M., Cohen J. A., Filippi M., et al. (2011). Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 69 292–302. 10.1002/ana.22366
    1. Posternak M. A., Miller I. (2001). Untreated short-term course of major depression: a meta-analysis of outcomes from studies using wait-list control groups. J. Affect. Disord. 66 139–146. 10.1016/S0165-0327(00)00304-9
    1. Rosti-Otajärvi E., Hämäläinen P., Wiksten A., Hakkarainen T., Ruutiainen J. (2017). Validity and reliability of the Fatigue Severity Scale in Finnish multiple sclerosis patients. Brain Behav. 7:e00743. 10.1002/brb3.743
    1. Sadovnick A. D., Eisen K., Ebers G. C., Paty D. W. (1991). Cause of death in patients attending multiple sclerosis clinics. Neurology 41 1193–1193. 10.1212/WNL.41.8.1193
    1. San José A. M., Oreja-Guevara C., Lorenzo S. C., Notario L. C., Vega B. R., Pérez C. B. (2016). Psychotherapeutic and psychosocial interventions for managing stress in multiple sclerosis: the contribution of mindfulness-based interventions. Neurología 31 113–120. 10.1016/j.nrl.2015.07.014.
    1. Schirda B., Nicholas J. A., Prakash R. S. (2015). Examining trait mindfulness, emotion dysregulation, and quality of life in multiple sclerosis. Health Psychol. 34 1107–1115. 10.1037/hea0000215
    1. Schulz K. F., Grimes D. A. (2002). Sample size slippages in randomised trials: exclusions and the lost and wayward. Lancet 359 781–785. 10.1016/S0140-6736(02)07882-0
    1. Senders A., Bourdette D., Hanes D., Yadav V., Shinto L. (2014). Perceived stress in multiple sclerosis: the potential role of mindfulness in health and well-being. J. Evid. Based Complement. Altern. Med. 19 104–111. 10.1177/2156587214523291
    1. Sheehan D. V., Lecrubier Y., Sheehan KH, Amorim P., Janavs J., Weiller al. (1998). The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 59(Suppl. 20) 22–33.
    1. Siegel D. J. (2015). The Developing Mind: How Relationships and the Brain Interact to Shape Who We Are. New York City, NY: Guilford Publications.
    1. Siegert R. J., Abernethy D. A. (2005). Depression in multiple sclerosis: a review. J. Neurol. Neurosurg. Psychiatry 76 469–475. 10.1136/jnnp.2004.054635
    1. Simpson R., Booth J., Lawrence M., Byrne S., Mair F., Mercer S. (2014). Mindfulness based interventions in multiple sclerosis-a systematic review. BMC Neurol. 14:15. 10.1186/1471-2377-14-15
    1. Smith E. L., Driskell L. D. (2016). Clinical utility and psychometric properties of the functional assessment of multiple sclerosis for individuals with multiple sclerosis. Rehabil. Psychol. 61 218–219. 10.1037/rep0000094
    1. Stevens J. (1986). Applied Multivariate Statistics for the Social Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates
    1. Tavee J., Rensel M., Planchon S. M., Butler R. S., Stone L. (2011). Effects of meditation on pain and quality of life in multiple sclerosis and peripheral neuropathy: a pilot study. Int. J. MS Care 13 163–168. 10.7224/1537-2073-13.4.163
    1. Thomas P. W., Thomas S., Hillier C., Galvin K., Baker R. (2006). Psychological interventions for multiple sclerosis. Cochrane Database Syst. Rev. CD004431. 10.1002/14651858.CD004431.pub2
    1. Ulrichsen K. M., Kaufmann T., Dørum E. S., Kolskår K. K., Richard G., Alnæs D., et al. (2016). Clinical utility of mindfulness training in the treatment of fatigue after stroke, traumatic brain injury and multiple sclerosis: a systematic literature review and meta-analysis. Front. Psychol. 7:912. 10.3389/fpsyg.2016.00912.
    1. Veehof M. M., Trompetter H. R., Bohlmeijer E. T., Schreurs K. M. G. (2016). Acceptance-and mindfulness-based interventions for the treatment of chronic pain: a meta-analytic review. Cogn. Behav. Ther. 45 5–31. 10.1080/16506073.2015.1098724.
    1. Wallin M. T., Wilken J. A., Turner A. P., Williams R. M. (2006). Depression and multiple sclerosis: review of a lethal combination. J. Rehabil. Res. Dev. 43 45–62. 10.1682/JRRD.2004.09.0117
    1. Wang Y. P., Gorenstein C. (2013). Psychometric properties of the beck depression inventory-II: a comprehensive review. Rev. Bras. Psiquiatr. 35 416–431. 10.1590/1516-4446-2012-1048

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다